Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

New onset diabetes, type 1 diabetes and COVID-19

Open access
Boddu, Sirisha Kusuma, Aurangabadkar, Geeta, Kuchay, Mohammad Shafi · 2020 · Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Abstract

Background and aims New data has emerged regarding higher risk of coronavirus disease 2019 (COVID-19), and its severity and complications in patients with type 2 diabetes mellitus (T2DM). However, there is a dearth of evidence regarding type 1 diabetes mellitus (T1DM). This article explores the possibility of COVID 19 induced diabetes and highlights a potential bidirectional link between COVID 19 and T1DM. Methods A literature search was performed with Medline (PubMed), Scopus, and Google Scholar electronic databases till October 2020, using relevant keywords (COVID-19 induced diabetes; COVID-19 and type 1 diabetes; COVID-19 induced DKA; new-onset diabetes after SARS-CoV-2 infection) to extract relevant studies describing relationship between COVID-19 and T1DM. Results Past lessons and new data teach us that severe acute respiratory syndrome coronaviruses (SARS-CoV and SARS-CoV-2) can enter islet cells via angiotensin converting enzyme-2 (ACE-2) receptors and cause reversible β-cell damage and transient hyperglycemia. There have been postulations regarding the potential new-onset T1DM triggered by COVID-19. This article reviews the available evidence regarding the impact and interlink between COVID-19 and Τ1DM. We also explore the mechanisms behind the viral etiology of Τ1DM. Conclusions SARS-CoV-2 can trigger severe diabetic ketoacidosis at presentation in individuals with new-onset diabetes. However, at present, there is no hard evidence that SARS-CoV-2 induces T1DM on it’s own accord. Long term follow-up of children and adults presenting with new-onset diabetes during this pandemic is required to fully understand the type of diabetes induced by COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dsx.2020.11.012

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 64

  1. 2006, DIAMOND Project Group Incidence and trends of childhood type 1 diabetes worldwide 1990–1999, Diabet Med, 23, 857, 10.1111/j.1464-5491.2006.01925.x · DOI · Paper page
  2. Chee, 2020, Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus, Diabetes Res Clin Pract, 164, 108166, 10.1016/j.diabres.2020.108166 · DOI · Paper page
  3. Sardu, 2020, Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?, Diabetes Care, 43, 1408, 10.2337/dc20-0723 · DOI · Paper page
  4. Li, 2020, COVID-19 infection may cause ketosis and ketoacidosis, Diabetes Obes Metabol
  5. Apicella, 2020, COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The lancet, Diabetes & Endocrinology, 8, 782
  6. Reddy, 2020, Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature, Diabetes Metab Syndr, 14, 1459, 10.1016/j.dsx.2020.07.050 · DOI
  7. Unsworth, 2020, New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K, Diabetes Care, 10.2337/dc20-1551 · DOI · Paper page
  8. Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4 · DOI · Paper page
  9. Filippi, 2008, Viral trigger for type 1 diabetes: pros and cons, Diabetes, 57, 2863, 10.2337/db07-1023 · DOI · Paper page
  10. Coppieters, 2012, Virus infections in type 1 diabetes, Cold Spring Harb Perspect Med, 2, 10.1101/cshperspect.a007682 · DOI
  11. Imagawa, 2000, A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group, N Engl J Med, 342, 301, 10.1056/NEJM200002033420501 · DOI · Paper page
  12. Imagawa, 2003, Fulminant type 1 diabetes: a nationwide survey in Japan, Diabetes Care, 26, 2345, 10.2337/diacare.26.8.2345 · DOI · Paper page
  13. Sano, 2008, A case of fulminant type 1 diabetes mellitus after influenza B infection, Diabetes Res Clin Pract, 79, e8, 10.1016/j.diabres.2007.10.030 · doi:10.1016/j.diabres.2007.10.030
  14. Goto, 2008, A case of fulminant type 1 diabetes associated with significant elevation of mumps titers, Endocr J, 55, 561, 10.1507/endocrj.K07E-126 · DOI
  15. Akatsuka, 2009, A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody, Diabetes Res Clin Pract, 84, e50, 10.1016/j.diabres.2009.03.009 · DOI
  16. Hwang, 2010, Fulminant Type 1 diabetes mellitus associated with acute hepatitis A, Diabet Med, 27, 366, 10.1111/j.1464-5491.2010.02930.x · DOI
  17. Christen, 2004, A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes, J Clin Invest, 114, 1290, 10.1172/JCI200422557 · doi:10.1172/jci200422557
  18. Horwitz, 1998, Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry, Nat Med, 4, 781, 10.1038/nm0798-781 · DOI · Paper page
  19. Schulte, 2010, Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection, Viral Immunol, 23, 99, 10.1089/vim.2009.0072 · DOI
  20. Laitinen, 2014, Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes, Diabetes, 63, 446, 10.2337/db13-0619 · DOI · Paper page
  21. Oikarinen, 2014, Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes, Diabetes, 63, 655, 10.2337/db13-0620 · DOI
  22. Stene, 2010, Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY), Diabetes, 59, 3174, 10.2337/db10-0866 · DOI · Paper page
  23. Salminen, 2004, Isolation of enterovirus strains from children with preclinical Type 1 diabetes, Diabet Med, 21, 156, 10.1111/j.1464-5491.2004.01097.x · DOI
  24. Dahlquist, 2004, Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based casecontrol study, Diabetes Care, 27, 285, 10.2337/diacare.27.1.285 · doi:10.2337/diacare.27.1.285
  25. Sadeharju, 2003, Enterovirus infections as a risk factor for type I diabetes: virus analyses in a dietary intervention trial, Clin Exp Immunol, 132, 271, 10.1046/j.1365-2249.2003.02147.x · DOI
  26. Hiemstra, 2001, Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase, Proc Natl Acad Sci U S A, 98, 3988, 10.1073/pnas.071050898 · DOI · Paper page
  27. Honeyman, 2010, Evidence for molecular 549 mimicry between human T cell epitopes in rotavirus and pancreatic islet 550 autoantigens, J Immunol, 184, 2204, 10.4049/jimmunol.0900709 · DOI
  28. Bian, 2016, Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays, Diabetes, 65, 285, 10.2337/db15-0179 · DOI
  29. Nilsson, 2015, Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children, J Med Virol, 87, 1130, 10.1002/jmv.24127 · DOI
  30. Tapia, 2011, Longitudinal study 533 of parechovirus infection in infancy and risk of repeated positivity for multiple islet 534 autoantibodies: the MIDIA study, Pediatr Diabetes, 12, 58, 10.1111/j.1399-5448.2010.00658.x · DOI
  31. Yeung, 2011, Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies, BMJ, 342, d35, 10.1136/bmj.d35 · DOI · Paper page
  32. Lönnrot, 2017, Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study, Diabetologia, 60, 1931, 10.1007/s00125-017-4365-5 · DOI · Paper page
  33. Fignani, 2020, SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 is expressed in human pancreatic islet β-cells and is upregulated by inflammatory stress, bioRxiv
  34. Yang, 2006, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS, Diabet Med, 23, 623, 10.1111/j.1464-5491.2006.01861.x · DOI · Paper page
  35. Pitocco, 2020, Lack of type 1 diabetes involvement in SARS-COV-2 population: only a particular coincidence?, Diabetes Res Clin Pract, 164, 108220, 10.1016/j.diabres.2020.108220 · DOI
  36. Fadini, 2020, Prevalence and impact of diabetes among people infected with SARS-CoV-2, J Endocrinol Invest, 43, 867, 10.1007/s40618-020-01236-2 · DOI · Paper page
  37. Joshi, 1999, Infections in patients with diabetes mellitus, N Engl J Med, 341, 1906, 10.1056/NEJM199912163412507 · DOI · Paper page
  38. Tiwari, 2011, Sepsis in diabetes: a bad duo, Diabetes Metab Syndr, 5, 222, 10.1016/j.dsx.2012.02.026 · DOI
  39. Carey, 2018, Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study, Diabetes Care, 41, 513, 10.2337/dc17-2131 · DOI · Paper page
  40. Magliano, 2015, Excess risk of dying from infectious causes in those with type 1 and type 2 diabetes, Diabetes Care, 38, 1274, 10.2337/dc14-2820 · DOI
  41. Wang, 2011, Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia, BMC Infect Dis, 11, 104, 10.1186/1471-2334-11-104 · DOI
  42. Wu, 2020, Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study, BMJ Open Diabetes Res Care, 8, 10.1136/bmjdrc-2020-001476 · DOI · Paper page
  43. Ebekozien, 2020, Type 1 diabetes and COVID-19: preliminary findings from a multicenter surveillance study in the U.S, Diabetes Care, 43, e83, 10.2337/dc20-1088 · DOI
  44. Barron, 2020, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, The lancet Diabetes & endocrinology, 8, 813, 10.1016/S2213-8587(20)30272-2 · DOI · Paper page
  45. Ludvigsson, 2020, Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults, Acta Paediatr, 109, 1088, 10.1111/apa.15270 · DOI · Paper page
  46. Holman, 2020, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. The lancet, Diabetes & Endocrinology., 8, 823
  47. Salman, 2020, Hypoglycemia due to hydroxychloroquine, an uncommon association but to keep in mind, case report and review of literature, J Diabetes Metab Disord Control, 7, 6, 10.15406/jdmdc.2020.07.00193 · DOI
  48. Unübol, 2011, Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis, J Clin Rheumatol, 17, 46, 10.1097/RHU.0b013e3182098e1f · DOI
  49. Paengsai, 2019, Recommended first-line antiretroviral therapy regimens and risk of diabetes mellitus in HIV-infected adults in resource-limited settings, Open Forum Infect Dis, 6, ofz298, 10.1093/ofid/ofz298 · DOI
  50. Deng, 2020, Corticosteroids in diabetes patients infected with COVID-19, Ir J Med Sci, 1
  51. Yan, 2020, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, 367, 1444, 10.1126/science.abb2762 · DOI · Paper page
  52. Jin, 2020, Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms, Gut, 69, 1002, 10.1136/gutjnl-2020-320926 · DOI · Paper page
  53. Fan, 2020, Clinical features of COVID-19-related liver functional abnormality, Clin Gastroenterol Hepatol, 18, 1561, 10.1016/j.cgh.2020.04.002 · DOI · Paper page
  54. Hadi, 2020, Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members, Pancreatology, 20, 665, 10.1016/j.pan.2020.04.021 · DOI · Paper page
  55. Anand, 2020, Acute pancreatitis in a COVID-19 patient, Br J Surg, 107, 10.1002/bjs.11657 · DOI
  56. Ghosh, 2020, COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes, Diabetes & Metabolic Syndrome, Clin Res Rev
  57. Wang, 2020, Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia, Gastroenterology, 159, 367, 10.1053/j.gastro.2020.03.055 · DOI · Paper page
  58. Szatmary P, Arora A, Raraty MGT, Dunne DFJ, Baron RD, Halloran CM. Emerging phenotype of SARS-CoV2 associated pancreatitis. Gastroenterology. doi: 10.1053/j.gastro.2020.05.069. · DOI
  59. Ceriello, 2020, Why is hyperglycemia worsening COVID-19 and its prognosis?, Diabetes Obes Metabol, 10.1111/dom.14098 · DOI
  60. Rabbone, 2020, Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?, Diabetes Care, 10.2337/dc20-1321 · DOI · Paper page
  61. Basatemur, 2020, Paediatric critical care referrals of children with diabetic ketoacidosis during the COVID-19 pandemic, Arch Dis Child
  62. Kamrath, 2020, Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany, JAMA, 324, 801, 10.1001/jama.2020.13445 · DOI · Paper page
  63. Potier, 2020, COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes, Diabetes Metab, S1262–3636
  64. Kuchay, 2020, Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19, Diabetes Metab Syndr, 14, 2039, 10.1016/j.dsx.2020.10.015 · DOI

Cited by

See all 185

Metadata

Authors
Boddu, S. K., Aurangabadkar, G., & Kuchay, M. S.
Venue
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Publisher
Elsevier BV
Published
2020-11
Volume
14
Issue
6
Pages
2211-2217
ISSN
1871-4021 (ISSN-L)
OpenAlex
W3100694757
Cited by
185
References
8
FWCI
19.10
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New onset diabetes, type 1 diabetes and COVID-19. https://app.cochat.ai/papers/10.1016/j.dsx.2020.11.012
The paper
Boddu, S. K., Aurangabadkar, G., & Kuchay, M. S. (2020). New onset diabetes, type 1 diabetes and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2020.11.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.